Percutaneous transmyocardial laser revascularisation

Comment

J Harbison et al. Lancet. 2001.

. 2001 Feb 24;357(9256):638-9.

doi: 10.1016/s0140-6736(05)71433-1.

No abstract available

Comment on

Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial.
Schofield PM, Sharples LD, Caine N, Burns S, Tait S, Wistow T, Buxton M, Wallwork J. Schofield PM, et al. Lancet. 1999 Feb 13;353(9152):519-24. doi: 10.1016/s0140-6736(98)11478-2. Lancet. 1999. PMID: 10028979 Clinical Trial.
Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison.
Burkhoff D, Schmidt S, Schulman SP, Myers J, Resar J, Becker LC, Weiss J, Jones JW. Burkhoff D, et al. Lancet. 1999 Sep 11;354(9182):885-90. doi: 10.1016/s0140-6736(99)08113-1. Lancet. 1999. PMID: 10489946 Clinical Trial.
Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels.
Oesterle SN, Sanborn TA, Ali N, Resar J, Ramee SR, Heuser R, Dean L, Knopf W, Schofield P, Schaer GL, Reeder G, Masden R, Yeung AC, Burkhoff D. Oesterle SN, et al. Lancet. 2000 Nov 18;356(9243):1705-10. doi: 10.1016/s0140-6736(00)03203-7. Lancet. 2000. PMID: 11095257 Clinical Trial.